Source: Eur Respir J, 57 (3) 2004077; 10.1183/13993003.04077-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sagal Mohamed, Claudio U. Köser, Max Salfinger, Wladimir Sougakoff, Scott K. Heysell. Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?. Eur Respir J, 57 (3) 2004077; 10.1183/13993003.04077-2020

Member's Comments

No comment yet.

Related content which might interest you: Next-generation sequencing and assessment of tumour mutational burden: are these tools ready for clinical routine use? Source: International Congress 2019 – Molecular profiling and personalised treatment concepts in advanced non-small cell lung cancer: pertinent clinical dilemmas Year: 2019 Individualising treatment for tuberculosis: what has whole genome sequencing taught us so far? Source: Virtual Congress 2020 – Respiratory infections Year: 2020 Zoonotic tuberculosis in humans assessed by next-generation sequencing: an 18-month nationwide study in Lebanon Source: Eur Respir J, 55 (1) 1900513; 10.1183/13993003.00513-2019 Year: 2020 Paediatric interventional bronchology: catching up with new technology? Source: International Congress 2019 – Paediatric Year in review Year: 2019 Omics and single molecule detection: the future of TB diagnostics Source: Eur Respir Mon 2012; 58: 144-153 Year: 2012 The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019 From traditional bacteriology to rapid molecular methods: the revolution is going on Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012 Mutational screening in Italian patients with primary ciliary dyskinesia by next-generation sequencing (NGS) Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood Year: 2016 Interventional pneumology in Europe: cutting-edge technology Source: International Congress 2019 – Chinese programme 2019: Part I Year: 2019 Comparative mycobacterial genomics as a tool for drug target and antigen discovery Source: Eur Respir J 2002; 20: 78S-86S Year: 2002 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Screening new entrants for tuberculosis in Liverpool; how practicable are current guidelines? Source: Eur Respir J 2002; 20: Suppl. 38, 23s Year: 2002 Tuberculosis diagnostics: which target product profiles should be prioritised? Source: Eur Respir J 2014; 44: 537-540 Year: 2014 A new era for Assembly 1: general pneumology Source: Breathe, 15 (2) 147; 10.1183/20734735.0135-2019 Year: 2019 The new horizons of molecular diagnosis: do we still need conventional microbiology? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Tele-health technologies  Source: International Congress 2017 – Innovation in diagnosing and monitoring respiratory disease Year: 2017 Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS) Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017–2019: an ECDC pilot study Source: Eur Respir J, 57 (1) 2002272; 10.1183/13993003.02272-2020 Year: 2021